Substrate activation of butyrylcholinest
β
Shyh-Ying Chiou; Yon-Gi Wu; Yan-Fu Lin; Long-Yau Lin; Gialih Lin
π
Article
π
2007
π
John Wiley and Sons
π
English
β 237 KB
## Abstract Carbamates are used to treat Alzheimer's disease. These compounds inhibit acetylcholinesterase and butyrylcholinesterase. The goal of this work is to use the substrate analogs of butyrylcholinesterase, 3,3βdimethylbutylβ__N__β__n__βbutylcarbamate (1) and 2βtrimethylsilylβethylβ__N__β__n